Aurobindo Pharma launches new manufacturing facility in Telangana
Pharmaceutical firm Aurobindo Pharma has launched a new biologics manufacturing facility in Telangana's Borapatla village, Sangareddy district. This marks the firm's entry into biologics contract manufacturing with an investment of Rs 1,200 crore.
This new facility will produce biologic medicines for global markets, with US pharma giant MSD being the first major client.
Also Read: HLL Lifecare plans to open 550 pharmacies by 2027